Inotiv, Inc. Update: Navigating Chapter 11 Bankruptcy

This guide helps you understand the recent financial news regarding Inotiv, Inc., a company that provides drug research and development services to the pharmaceutical industry.

1. What happened?

Inotiv, Inc. filed for Chapter 11 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware. To keep the business running during this process, the company secured $65.5 million in emergency funding, known as Debtor-in-Possession (DIP) financing. Simultaneously, the Nasdaq Stock Market issued a delisting notice because the bankruptcy filing violates their rules for remaining on the exchange.

2. When did it happen?

The company filed for bankruptcy on June 3, 2026. They finalized the $65.5 million loan on June 5, 2026, with Acquiom Agency Services acting as the lead agent for the lenders. Nasdaq issued the delisting notice on June 4, 2026, which means the company’s stock will stop trading on the main exchange.

3. Why did it happen?

Inotiv is using Chapter 11 to reorganize its debt under court supervision. The $65.5 million loan provides the cash needed to pay employees, benefits, and essential vendors. This funding keeps the business open while the company negotiates a plan to fix its finances.

4. Why does this matter?

This is a major financial overhaul. The new loan has "superpriority" status, meaning these lenders get paid before existing unsecured creditors. The Nasdaq delisting also makes it harder to trade the stock. Shares will likely move to over-the-counter (OTC) markets, where there is usually less trading activity and significantly less transparency.

5. Who is affected?

• Investors: This is a high-risk situation. In bankruptcy, shareholders are last in line to be paid. There is a high risk that the reorganization will result in more shares being issued, significantly diluting your ownership, or that your shares will be canceled entirely, leaving you with nothing.
• Employees: While the new loan covers payroll, bankruptcy often leads to restructuring, layoffs, or the sale of business units.
• Customers: Inotiv provides vital research services. While the company plans to keep working, the uncertainty of bankruptcy may cause clients to look elsewhere for long-term projects.

6. What happens next?

The bankruptcy court now oversees the company. To keep the $65.5 million in funding, Inotiv must hit specific financial targets set by the lenders. The company aims to replace this emergency loan with an "Exit Term Loan" to help it eventually emerge from bankruptcy as a reorganized business. The company hasn't provided much detail yet on their long-term strategy for profitability, so we are waiting to see how the court-mandated plan takes shape.

7. What should investors/traders know?

• For the day trader: Expect wild price swings. Bankruptcy news often causes erratic trading as people speculate on the company’s future.
• For the casual investor: This is a "distressed" situation. The company is in survival mode, and you face a high risk of losing your entire investment. Most long-term investors avoid companies in bankruptcy because the path to recovery is difficult and usually results in significant losses for current shareholders.

Bottom Line: If you are considering holding or buying, ask yourself if you are prepared for the possibility that your investment could go to zero. In bankruptcy, the "recovery" process is rarely designed to benefit the current shareholders.

Disclaimer: I am an AI, not a financial advisor. This summary is for informational purposes only and should not be considered professional investment advice. Always do your own research before making financial decisions.